This trial will help researchers understand why patients with heart failure and preserved ejection fraction (HFpEF) are intolerant to exercise, and if regular physical activity can help improve this.
0 Primary · 1 Secondary · Reporting Duration: 12 weeks
Experimental Treatment
50 Total Participants · 3 Treatment Groups
Primary Treatment: Afferent block · No Placebo Group · N/A
Age 21 - 85 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: